Effects of Su-13437, a new hypolipidemic drug, upon synthesis in vivo of hepatic and carcass total fatty acids and total cholesterol.
D000085:Acetates / Q000378:metabolism; D000818:Animals; D002247:Carbon Isotopes; D002784:Cholesterol / Q000096:biosynthesis / Q000097:blood*; D005227:Fatty Acids / Q000096:biosynthesis / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D008099:Liver / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008660:Metabolism / Q000187:drug effects; D051379:Mice; D009281:Naphthalenes / Q000494:pharmacology*; D009929:Organ Size; D010636:Phenols / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology*; D012964:Sodium / Q000378:metabolism; D013997:Time Factors; D014280:Triglycerides / Q000097:blood*
D000085:Acetates; D002247:Carbon Isotopes; D005227:Fatty Acids; D009281:Naphthalenes; D010636:Phenols; D011422:Propionates; D014280:Triglycerides; D002784:Cholesterol; D012964:Sodium; D005947:Glucose